CDRH Transparency Update

You are subscribed to CDRH Transparency for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

Evaluation of Automatic Class III Designation (De Novo) Summaries

• COBAS INTEGRA 800 Tina-quant HbA1cDx Gen.2 assay (K121291)

CDRH Transparency home page 

 

---

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

---

This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420